Geneos Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$82K Sell
648
-1,098
-63% -$139K ﹤0.01% 1330
2025
Q1
$223K Buy
1,746
+873
+100% +$112K ﹤0.01% 1184
2024
Q4
$115K Buy
873
+300
+52% +$39.7K ﹤0.01% 1013
2024
Q3
$83.5K Sell
573
-81
-12% -$11.8K ﹤0.01% 1017
2024
Q2
$89.8K Sell
654
-292
-31% -$40.1K ﹤0.01% 897
2024
Q1
$130K Buy
946
+502
+113% +$68.9K 0.01% 795
2023
Q4
$60.3K Sell
444
-200
-31% -$27.2K ﹤0.01% 1006
2023
Q3
$78.8K Buy
644
+92
+17% +$11.3K ﹤0.01% 940
2023
Q2
$70.1K Hold
552
﹤0.01% 979
2023
Q1
$71.3K Sell
552
-41
-7% -$5.3K ﹤0.01% 959
2022
Q4
$77.9K Buy
593
+63
+12% +$8.27K ﹤0.01% 899
2022
Q3
$61K Sell
530
-709
-57% -$81.6K ﹤0.01% 960
2022
Q2
$148K Buy
1,239
+27
+2% +$3.23K 0.01% 859
2022
Q1
$157K Sell
1,212
-921
-43% -$119K 0.01% 904
2021
Q4
$325K Sell
2,133
-261
-11% -$39.8K 0.01% 706
2021
Q3
$380K Sell
2,394
-47
-2% -$7.46K 0.01% 647
2021
Q2
$402K Sell
2,441
-270
-10% -$44.5K 0.02% 619
2021
Q1
$419K Sell
2,711
-1,568
-37% -$242K 0.01% 679
2020
Q4
$487K Sell
4,279
-5,192
-55% -$591K 0.02% 547
2020
Q3
$1.26M Buy
9,471
+7,226
+322% +$964K 0.07% 257
2020
Q2
$303K Buy
2,245
+186
+9% +$25.1K 0.02% 547
2020
Q1
$224K Buy
2,059
+11
+0.5% +$1.2K 0.02% 578
2019
Q4
$249K Buy
2,048
+266
+15% +$32.3K 0.01% 615
2019
Q3
$177K Sell
1,782
-3,603
-67% -$358K 0.01% 696
2019
Q2
$587K Buy
5,385
+52
+1% +$5.67K 0.04% 372
2019
Q1
$596K Buy
5,333
+374
+8% +$41.8K 0.04% 358
2018
Q4
$470K Buy
4,959
+761
+18% +$72.1K 0.03% 390
2018
Q3
$511K Buy
4,198
+128
+3% +$15.6K 0.03% 383
2018
Q2
$447K Sell
4,070
-1,245
-23% -$137K 0.03% 344
2018
Q1
$567K Sell
5,315
-504
-9% -$53.8K 0.05% 281
2017
Q4
$621K Sell
5,819
-13,678
-70% -$1.46M 0.06% 279
2017
Q3
$2.16M Buy
19,497
+906
+5% +$100K 0.21% 120
2017
Q2
$1.92M Buy
18,591
+618
+3% +$63.9K 0.2% 118
2017
Q1
$1.8M Buy
17,973
+13,455
+298% +$1.35M 0.19% 120
2016
Q4
$399K Sell
4,518
-93
-2% -$8.21K 0.05% 300
2016
Q3
$444K Buy
4,611
+411
+10% +$39.6K 0.06% 266
2016
Q2
$367K Buy
4,200
+225
+6% +$19.7K 0.05% 307
2016
Q1
$355K Buy
+3,975
New +$355K 0.05% 303